Jan 6 (Reuters) - Chat platform Discord filed confidentially for an initial public offering in the United States, Bloomberg News reported on Tuesday, citing people familiar with the matter. The U.S.

A Python-based malware family known as VVS stealer has been observed using advanced obfuscation and stealth techniques to target Discord users and extract sensitive ...

In a nutshell: Discord is finally acknowledging a long-running problem: its Windows 11 app can quietly chew through far more RAM than it should. And with memory prices climbing again, users are paying ...

Discord now admits that their Windows 11 app uses unnecessary amounts of memory, reports Windows Latest. To address this, the communication platform is currently testing a new feature that ...

Discord has launched its own annual user recap called Discord Checkpoint, similar to Spotify Wrapped. The feature summarizes a user's 2025 activity, including messages sent, time in voice chat, and ...

Discord has followed the lead of platforms like Spotify and created its own version of Spotify Wrapped for its users. Discord is a popular online hangout spot where people can play video games, chat, ...

Rolling out from Dec. 4, Discord Checkpoint is the voice messaging app's first ever year-in-review feature. Discord hasn't committed to making this an annual event going forward, stating that ...

The year is quickly coming to an end, and that means tech platforms are tripping over themselves to roll out their year-end recaps—all hoping to capture the virality that Spotify’s Wrapped ...

Fintel reports that on November 3, 2025, BMO Capital upgraded their outlook for Replimune Group (NasdaqGS:REPL) from Underperform to Market Perform. As of October 30, 2025, the average one-year price ...

While the IPO market is frozen during the government shutdown, Discord is poised for an initial public offering that would break a multiyear drought in gaming and interactive entertainment stocks to ...

Shares of Replimune Group, Inc. (NASDAQ:REPL) are rising Monday after the clinical stage biotechnology company shared an important regulatory update. What To Know: Replimune said the U.S. Food and ...